- Home
- HCAT
HCAT
Health Catalyst Inc
as 07-26-2024 4:00pm EST
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SOUTH JORDAN |
| Market Cap: | 378.4M | IPO Year: | 2019 |
| Target Price: | $12.30 | AVG Volume (30 days): | 595.5K |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.45 - $14.37 | Next Earning Date: | 08-07-2024 |
| Revenue: | $296,793,000 | Revenue Growth: | 5.24% |
| Revenue Growth (this year): | 6.1% | Revenue Growth (next year): | 11.65% |
Stock Insider Trading Activity of Health Catalyst Inc (HCAT)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Llewelyn Linda | HCAT | Chief People Officer | Jul 15 '24 | Sell | $6.51 | 1,290 | $8,397.90 | 119,864 | SEC Form 4 |
| LeSueur Daniel | HCAT | Chief Operating Officer | Jul 3 '24 | Sell | $6.15 | 5,208 | $32,048.99 | 155,215 | SEC Form 4 |
| Llewelyn Linda | HCAT | Chief People Officer | Jun 17 '24 | Sell | $6.37 | 1,290 | $8,220.53 | 121,154 | SEC Form 4 |
| Alger Jason | HCAT | Chief Financial Officer | Jun 12 '24 | Sell | $6.83 | 2,823 | $19,281.09 | 118,170 | SEC Form 4 |
| Freeman Kevin Lee | HCAT | Chief Commercial Officer | Jun 11 '24 | Sell | $6.53 | 7,500 | $49,008.00 | 266,153 | SEC Form 4 |
| Landry Benjamin | HCAT | General Counsel | Jun 6 '24 | Sell | $6.71 | 2,387 | $16,017.96 | 104,625 | SEC Form 4 |
| LeSueur Daniel | HCAT | Chief Operating Officer | Jun 6 '24 | Sell | $6.72 | 11,923 | $80,064.14 | 160,423 | SEC Form 4 |
| Landry Benjamin | HCAT | General Counsel | May 31 '24 | Sell | $6.61 | 12,577 | $83,132.71 | 108,312 | SEC Form 4 |
| Llewelyn Linda | HCAT | Chief People Officer | May 15 '24 | Sell | $7.00 | 2,066 | $14,462.00 | 124,160 | SEC Form 4 |
| Llewelyn Linda | HCAT | Chief People Officer | Apr 15 '24 | Sell | $6.11 | 2,005 | $12,250.55 | 126,226 | SEC Form 4 |
| Llewelyn Linda | HCAT | Chief People Officer | Mar 15 '24 | Sell | $7.80 | 2,005 | $15,647.62 | 128,231 | SEC Form 4 |
| Burton Daniel D. | HCAT | Chief Executive Officer | Feb 27 '24 | Buy | $7.81 | 26,200 | $204,525.06 | 1,172,623 | SEC Form 4 |
| Llewelyn Linda | HCAT | Chief People Officer | Feb 15 '24 | Sell | $9.77 | 3,262 | $31,854.73 | 64,786 | SEC Form 4 |
| Llewelyn Linda | HCAT | Chief People Officer | Jan 16 '24 | Sell | $10.83 | 3,163 | $34,246.12 | 68,048 | SEC Form 4 |
| Llewelyn Linda | HCAT | Chief People Officer | Dec 15 '23 | Sell | $8.83 | 3,163 | $27,922.65 | 71,211 | SEC Form 4 |
| Llewelyn Linda | HCAT | Chief People Officer | Nov 15 '23 | Sell | $8.25 | 1,196 | $9,867.00 | 78,535 | SEC Form 4 |
Latest Health Catalyst Inc News
HCAT Breaking Stock News: Dive into HCAT Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Health Catalyst to Announce Second Quarter 2024 Operating Results and Host Conference Call on Wednesday, August 7, 2024
Simply Wall St.
8 days ago
Shareholders in Health Catalyst (NASDAQ:HCAT) are in the red if they invested three years ago
MT Newswires
8 days ago
Health Catalyst Secures $225 Million Loan Facility
PR Newswire
8 days ago
Health Catalyst Announces New Credit Facility for up to $225,000,000
MT Newswires
17 days ago
Evercore ISI Trims Price Target on Health Catalyst to $8 From $9, Maintains Outperform Rating
GOBankingRates
2 months ago
5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
AFP
2 months ago
Bumrah delivers as India beat Pakistan in low-scoring thriller
AFP
2 months ago
Italy beat Bosnia in final Euros warm-up
Compare HCAT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HCAT Health Catalyst Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.